Sector: Healthcare | Industry: Pharmaceuticals |
Company Contact | |
Address: | Suite 300, 1055 West Hastings Street VANCOUVER BC V6E 2E9 |
Tel: | N/A |
Website: | https://1933industries.com |
IR: | See website |
Key People | ||
N/A |
Business Overview |
1933 Industries Inc. is a Canada-based cannabis cultivator and producer. The Company is focused on the cultivation and manufacturing of a portfolio of cannabis consumer-packaged goods in a variety of formats for both the wholesale and retail markets. Its product offerings through its in-house brands, including wholesale flower, pre-rolls, and extracted products under the AMA and Level X brands for the Nevada market; and Canna Hemp, a national cannabidiol (CBD) brand of wellness products, which include tinctures, gummies, topicals and sports recovery products. The Company owns 91% of Alternative Medicine Association, LC (AMA) and 100% of Infused MFG LLC (Infused). AMA is a licensed medical and adult-use cannabis cultivation and extraction company, which produced its own AMA branded line of cannabis-based products and manufactures third-party brands. Infused produces the Canna Hemp line of hemp-based, CBD products. Infused's product line includes topicals, creams, vapes and others. |
Financial Overview |
For the six months ended 31 January 2024, 1933 Industries Inc revenues increased 11% to C$10.3M. Net loss decreased 20% to C$1.2M. Revenues reflect AMA segment increase of 25% to C$9.8M, United States segment increase of 19% to C$10.3M. Lower net loss reflects Fair value adjustment on sale of biologi decrease of 33% to C$2M (expense), Professional fees decrease of 69% to C$187K (expense). |
Employees: | 87 as of Jul 31, 2023 |
Reporting Currency: | Canadian Dollars |
Enterprise value: | $23.84M as of Jan 31, 2024 |
Annual revenue (TTM): | $19.27M as of Jan 31, 2024 |
EBITDA (TTM): | -$3.70M as of Jan 31, 2024 |
Net annual income (TTM): | -$13.06M as of Jan 31, 2024 |
Free cash flow (TTM): | -$1.58M as of Jan 31, 2024 |
Net Debt Last Fiscal Year: | $16.06M as of Jan 31, 2024 |
Shares outstanding: | 490,471,657 as of Mar 4, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |